Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Backgroud</h3><p>Dihydromyricetin (DMY), a natural flavonoid compound from the leaves of the Chinese medicinal herb <em>Vitis heyneana</em>,has been shown to have the potential to combat chemoresistance by inhibiting Nrf2/MRP2 signaling in colorectal cancer (CRC) cells. However, the precise underlying molecular mechanism and its therapeutic target are not well understood.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Purpose</h3><p>Our study aims to investigate the effects of DMY on multidrug resistance (MDR), and elucidate the underlying mechanisms.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Study design</h3><p><em>In vitro,</em> HCT116/OXA and HCT8/VCR cells were employed as our MDR models. The cells were treated with DMY (50 µM) or MK-571 (50 µM) plus oxaliplatin (OXA) (10 µM) or vincristine (VCR) (10 µM) for 48 h. <em>In vivo</em>, we used BALB/c mice as a CRC xenograft mouse model. BALB/c mice were given DMY (100 mg/kg), OXA (5 mg/kg) and DMY (100 mg/kg) combined with OXA (5 mg/kg) via intraperitoneal route every 2 days per week for 4 weeks.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>We used MTT and colony forming assays to detect DMY's ability to reverse MDR. Flow cytometric analysis was used to detect apoptosis. Immunocytochemistry was used to detect the localization of Nrf2 and NF-κB/p65. Western blot, qRT-PCR and reporter gene assays were employed to measure the protein and gene transcriptional levels (MRP2, Nrf2, NF-κB/p65). Moreover, chromatin immunoprecipitation (ChIP) assay was used to investigate the endogenous promoter occupancy of NF-κB/p65. Finally, immunohistochemistry and TUNEL staining were used to detect protein expression and apoptosis <em>in vivo</em>.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>DMY restored chemosensitivity (OXA and VCR) by inhibiting both MRP2 expression and its promoter activity in HCT116/OXA and HCT8/VCR cell lines. Furthermore, DMY could inhibit NF-κB/p65 expression, reducing NF-κB/p65 translocation to the nucleus to silence Nrf2 signaling, which is necessary for MRP2 expression. Overexpressing NF-κB/p65 expression reduced the reversal effect of DMY. In addition, NF-κB/p65 regulated Nrf2 expression by directly binding to its specific promoter region and activating its transcription. Finally, we proved that the combination of OXA and DMY has a synergistic tumor suppression effect <em>in vivo</em>.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>Our study provided a novel mechanism of DMY boosted chemosensitivity in human CRC. The downstream signals of DMY, NF-κB or Nrf2 could also be potential targets for the treatment of CRC.</p>

Dihydromyricetin Inhibits Cell Invasion and Down-Regulates Mmp-2/-9 Protein Expression Levels in Human Breast Cancer Cells

Matrine Inhibits Invasiveness and Metastasis of Human Malignant Melanoma Cell Line A375 in Vitro

Effects of genistein and daidzein on the cell growth, cell cycle, and differentiation of human and murine melanoma cells11The abbreviations used are: BSA, bovine serum albumin; FBS, fetal bovine serum; ECM, extracellular matrix; DMSO, dimethyl sulfoxide; PTK, protein tyrosine kinase.

Dihydromyricetin Inhibits Tumor Growth and Epithelial-Mesenchymal Transition through regulating miR-455-3p in Cholangiocarcinoma

Effects of Genistein and Daidzein on the Proliferation, Invasion, Migration and Adhesion of Melanoma Cells

Dihydromyricetin reverses MRP2-mediated MDR and enhances anticancer activity induced by oxaliplatin in colorectal cancer cells

Inhibitory effect of matrine on the in vitro invasiveness of human malignant melanoma cell line A375

INHIBITION OF MYRICETIN ON HUMAN LUNG ADENOCARCINOMA H460 CELL PROLIFERATION AND THE ROLE OF ERK PATHWAY

EFFECTS OF MYRICETIN ON HUMAN LUNG ADENOCARCINOMA CELL LINES AND ITS MECHANISM

Dihydromyricetin Induces Cell Apoptosis Via A P53-Related Pathway in Ags Human Gastric Cancer Cells

Mechanisms of dihydromyricetin against hepatocellular carcinoma elucidated by network pharmacology combined with experimental validation

EcR expression in the prothoracicotropic hormone‐producing neurosecretory cells of the Bombyx mori brain

[Inhibition of invasiveness and expression of heparanase-mRNA in human malignant melanoma cell line A375 by matrine].

Dihydromyricetin reverses MRP2-induced multidrug resistance by preventing NF-κB-Nrf2 signaling in colorectal cancer cell

Circuit design in nano-scale CMOS era: opportunities & challenges

Using Caffeoyl Pyrrolidine Derivative LY52, a Potential Inhibitor of Matrix Metalloproteinase-2, to Suppress Tumor Invasion and Metastasis

Etude anatomique et fonctionnelle du muscle demi-membraneux

Dihydroartemisinin inhibits angiogenesis in breast cancer via regulating VEGF and MMP-2/-9

[Dihydromyricetin reduces lipid accumulation in LO2 cells via AMPK/mTOR-mediated lipophagy pathway and inhibits HepG2 cell proliferation in vitro]

Dihydromyricetin suppresses tumor growth via downregulation of the EGFR/Akt/survivin signaling pathway

Experimental Study on Gensenoside Rh2 Inhibiting the Invasion and Migration of Breast Cancer Cells